To detect the synergistic effect of Cat D inhibition and TRAIL in an in vivo xenograft model, we subjected tumor-bearing mice to single (Pep A or TRAIL) or combined (Pep A plus TRAIL) treatments. This evidence concerns the gene TNFSF10 and neoplasm.